Eli Lilly Hikes Dividend

With all of the recent news about Pfizer lately, Eli Lilly’s dividend increase almost slipped under the radar. 

INDIANAPOLIS, Dec. 18 /PRNewswire-FirstCall/ — The board of directors of Eli Lilly and Company (NYSE: LLYNews) today announced a 6.25 percent increase in its quarterly dividend. The board declared a dividend for the first quarter of 2007 of $0.425 a share on outstanding common stock. This raises the annual indicated rate to $1.70 per share and represents the 40th consecutive year in which the company has increased the dividend payment.

Via: Yahoo

One comment

  1. Eli Lilly Zyprexa scandal

    Zyprexa off label promotion scandal is all over the news now.
    Lilly drug reps are alleged to have called their marketing ploy,”Viva zyprexa”.

    Eli Lilly zyprexa cost me over $250.00 a month supply out of my own pocket X 4 years and has up to ten times the risk (over non users) of causing diabetes and severe weight gain.

    Zyprexa which is only FDA approved for schizophrenia (.5-1% of pop) and some bipolar (2% pop) and then an even smaller percentage of theses two groups.
    So how does Zyprexa get to be the 7th largest drug sale in the world?
    Eli Lilly is in deep trouble for using their drug reps to ‘encourage’ doctors to write zyprexa for non-FDA approved ‘off label’ uses.

    The drug causes increased diabetes risk,and medicare picks up all the expensive fallout.There are now 7 states (and counting) going after Lilly for fraud and restitution.

    Only 9 percent of adult Americans think the pharmaceutical industry can be trusted right around the same rating as big tobacco.

    Daniel Haszard zyprexa-victims.com

Leave a Reply

Your email address will not be published. Required fields are marked *